McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100

McKesson Corporation (MCK) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, McKesson Corporation (MCK) trades at a P/E ratio of 26.8×. Over the past ten years it has ranged from 0.0× (December 2021) to 1,687× (June 2019); the current reading is higher than 68% of that period. That is above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 22.4× (13.61%)
FY2025 25.9× 8.87%
FY2024 23.8× 68.47%
FY2023 14.1× (66.29%)
FY2022 41.9× —
FY2021 0.0× —
FY2020 26.1× (98.25%)
FY2019 1,486× 144.38%
FY2018 608× 9,559.61%
FY2017 6.3× (60.74%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 20.1× (10.10%)
Mar 2026 22.4× (4.66%)
Dec 2025 23.5× (1.88%)
Sep 2025 23.9× (17.67%)
42 more quarters

Against its own ten years

Low 0.0× High 1,687×
Ten-year median 22.4×
Current reading's percentile 66

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on MCK